Caprolactam Market Is Segmented On The Basis Of Application, End-Use And Region 2012-2022

Global Caprolactam Market is expected to reach USD 15.30 billion by 2022, according to a new report by Grand View Research, Inc. Rising nylon 6 resin and fiber consumption, on account of increasing demand for electronics is expected to drive the market. Electronics industry growth in China has resulted in subsequently driving caprolactam demand over the past few years.

Caprolactam manufacturing requires low technical complexity along with lesser initial infrastructure investment thus encouraging new participants to enter the market. Technological innovations aimed at improving manufacturing process of the product in order to minimize release of ammonium sulfate as a by-product on account of its hazardous nature is expected to have a positive impact on the industry.

North America and Europe together accounted for over 35% of the global market volume share in 2014. Increasing focus on R&D for commercial production of bio-based caprolactam and resultant bio-nylon is expected to open new opportunities for market growth in the near future.

Access Full Research Report Global Caprolactam Market:
http://www.grandviewresearch.com/industry-analysis/caprolactam-market

Further key findings from the report suggest:

• Nylon 6 resins are expected to witness significant gains with projected growth at a CAGR of 5.1% from 2015 to 2022. Increasing consumption of nylon 6 resins for manufacturing of engineering plastics which are used as technical components in electrical & electronics and packaging industry is expected to accelerate market growth.
• Ammonia, cyclohexane, phenol and toluene are some of the key raw materials used for manufacturing caprolactam. Volatile raw material prices, limited availability and stringent regulations have been some of the primary factors challenging market growth.
• Engineering plastics accounted for over 15% of the global volume share in 2014. Rapid industrialization coupled with tremendous growth in the automotive sector, particularly in Asia Pacific, is expected to have a positive impact on the industry over the forecast period. Innovation in the field of electronics along with increasing consumption of smart phones, tablets, laptops and TVs has resulted in driving demand for engineering plastics, subsequently augmenting market growth.
• Asia Pacific caprolactam market was estimated at over 2,940.0 kilo tons in 2014. Encouragement of 100% Foreign Direct Investment by the Indian government for domestic automobile industry growth is expected to augment manufacturing sector. This is expected to fuel nylon 6 resins demand which in turn will have a positive impact on the caprolactam industry over the next seven years.
• The global industry is fragmented in nature, on account of presence of numerous companies globally. These include Sumitomo Chemicals, Honeywell, BASF, Toray, DSM, Alpek, Ube, Sinopec and Lanxess.
• In May 2015, Sumitomo Chemicals increased contract caprolactam price by USD 70 per metric ton to USD 1,880 per metric ton. In May 2015, BASF SE increased caprolactam prices by USD 0.05 per pound in North America.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/organic-chemicals-and-compounds

Grand View Research has segmented the Global Caprolactam Market on the basis of application, end-use and region:

Application Outlook (Volume, Kilo Tons, Revenue, USD Million, 2012 - 2022)

• Nylon 6 fibers
• Nylon 6 resins

End-Use Outlook (Volume, Kilo Tons, Revenue, USD Million, 2012 - 2022)

• Textile yarn
• Industrial yarn
• Engineering Plastics
• Carpet fibers & staple fibers

Regional Outlook (Volume, Kilo Tons, Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• MEA

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-caprolactam-market  

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Live Cell Imaging Market Is Projected To Grow With CAGR Of 8.3% Over The Forecast Period 2014-2025

Global Live Cell Imaging Market is expected to reach USD 9.3 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

Full Research Report on Global Live Cell Imaging Market Analysis: http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings from The Report Suggest:

• Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.
• Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.
• North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.
• Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.
• Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Live Cell Imaging Market on the basis of product, application, technology, and region:

Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

• Equipment
• Consumable
• Software

Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• MEA
• South Africa  

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-live-cell-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Endoscopic Vessel Harvesting Systems Market Is Expected To Grow At A CAGR Of 6.1% From 2017 To 2025

Global Endoscopic Vessel Harvesting Systems Market is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of the patient population toward minimally invasive cardiac surgeries is one of the key factors expected to drive the market in the coming few years.

The introduction of endoscopic vessel harvesting technology in the field of cardiac surgery was a significant milestone in 1996. According to estimates by the Texas Heart Institute, every year over 200,000 procedures were performed in the U.S. Also, based on the statistics published by the department of surgery (Washington University School of Medicine in St. Louis), they perform Coronary Artery Bypass Grafting (CABG) surgeries on approximately 0.5 million people very year. The growing demand for these procedures and technologically advanced surgical procedures are among few factors anticipated to boost the market over the forecast period.

The presence of favorable reimbursement policies in the U.S. pertaining to CABG surgeries is anticipated to increase the number these surgeries. On July 2016, the Department of Health & Human Services announced that it will begin implementing bundled payment models for high-quality, coordinated cardiac and hip fracture care. The market is highly concentrated with a limited number of products and market players operating in this space. Many studies stated that the open vessels harvesting technique is as effective as minimally invasive vessels harvesting technique. However, the growing awareness regarding benefits of Endoscopic Vessels Harvesting (EVH), such as minimally invasive nature, less complications, and quick recuperation are some of the factors that are anticipated to propel its growth during the forecast period.

Full research report on Global Endoscopic Vessel Harvesting Systems Market Analysis:
http://www.grandviewresearch.com/industry-analysis/endoscopic-vessel-harvesting-system-market

Further Key Findings From the Report Suggest:

• The global endoscopic vessel harvesting system market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% from 2017 to 2025
• Reusable EVH systems emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 2,136.0 million by 2025
• Global disposable EVH systems was USD 639.3 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. The regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including MAQUET Holding B.V. & Co. KG; CARDIO MEDICAL GmbH; Terumo Cardiovascular Group; Med Europe S.r.l. (Elite Life Care); LivaNova plc. (Sorin and Cyberonics); and Saphena Medical, Inc. dominated the global endoscopic vessels harvesting systems market.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Endoscopic Vessel Harvesting Systems Market on the basis of product and region:

Endoscopic Vessel Harvesting SystemProduct Outlook (Revenue, USD Million, 2014 - 2025)

• Disposable
• Reusable

Endoscopic Vessel Harvesting SystemRegional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-endoscopic-vessel-harvesting-system-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hepatitis Therapeutics Market Size Is Anticipated To Reach $25.8 Billion By 2025

Global Hepatitis Therapeutics Market is expected to reach USD 25.8 billion by 2025 according to a new report by Grand View Research, Inc. The key factors driving market growth include the rising number of infected population, growing consumption of alcohol & drugs, increase in global geriatric population, and improvement in access to hepatitis medicines.

Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic hepatitis. The population at a greater risk of hepatitis include people with HIV infection & HCV-infected sexual partners, who inject drugs & use intranasal drugs, recipients of infected blood products, and other population groups who live in unhygienic conditions.

According to the WHO, globally around 400 million people are infected with at least one form of hepatitis and every year nearly 1.4 people die due to the condition. Various government and private agencies are actively involved in the vaccination drive to prevent hepatitis. Hepatitis C leads to more serious complications compared to hepatitis A and B. As per WHO estimates, nearly 150 million are impacted by hepatitis C infection globally. Moreover, a significant number of hepatitis C patients develop liver cancer or liver cirrhosis and nearly 700,000 people die due to hepatitis C infection & associated conditions.

Access Full Research Report on Global Hepatitis Therapeutics Market:
http://www.grandviewresearch.com/industry-analysis/hepatitis-therapeutics-market

Further Key Findings From the Report Suggest:

• Due to very high prevalence of target disease coupled with subsequent increase in the treatment rate Hepatitis C accounted for the majority market share of 75.6% in 2016
• In 2016, North America held the largest share of nearly 42.9%. The key factors attributed to the regions high share include high patient awareness levels and the presence of advanced healthcare infrastructure. 
• Asia Pacific is anticipated to witness the maximum growth with a CAGR of 5.8% over the forecast period. High economic development coupled with rapidly increasing healthcare expenditure are amongst key factors attributing to the regions high growth rate.
• Key players include Gilead, Merck & Co. Inc., Johnson & Johnson, Bristol-Myers Squibb Company, and AbbVie Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Hepatitis Therapeutics Market on the disease type, and region:

Hepatitis Therapeutics Disease Type Outlook (Revenue, USD Million, 2014 - 2025)

• Hepatitis A
• Hepatitis B
• Hepatitis C
• Others

Hepatitis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release On Global Hepatitis Therapeutics Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-computer-aided-engineering-cae-market   

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiovascular Information System (CVIS) Market Is Segmented On The Basis Of System Type, Mode Of Operation, And Geography 2013-2024

Global Cardiovascular Information System (CVIS) Market is expected to reach USD 1.2 billion by 2024, according to a new report by Grand View Research Inc. The global cardiovascular devices industry is growing swiftly owing to the increasing prevalence of heart diseases and other cardiovascular problems. 

In accordance with the growing patient population there is an exponential surge in the patient history documents and patient data records. The resultant, rising burden of patient data is pushing forward the demand for effective management tools; thus, offering increased accessibility of patient information to surgeons and the healthcare staff and hence enhancing the operational efficiency of the practices. In addition, factors, such as technological advancements and the gradually growing awareness regarding the availability of these improved systems are expected to fuel the growth of the cardiovascular devices market. 

However, factors, such as high system costs and the lack of skilled operators are impeding the overall growth. In addition, the presence of alternative data management tools is challenging the adoption of the information systems specific to cardiovascular data management. Some of the key players in the market are implementing strategies to expand market share. For instance, companies, such as Philips Healthcare and GE Healthcare offer CVIS systems along with their cardiac imaging products.  

Access Full Research Report on Global Cardiovascular Information System Market: http://www.grandviewresearch.com/industry-analysis/cardiovascular-information-system-market

Further key findings from the study suggest:

• The CVIS segment captured the largest market share of the global market in 2015. Integration of these systems with imaging devices is responsible for the highest adoption rate of this segment.
• Owing to the high cost of these systems, the CVIS segment is expected to maintain its dominance during the forecast period
• The cloud-based segment is anticipated to exhibit the fastest growth rate during the forecast period. The associated advantages, such as the affordable cost, remote accessibility of data, and the user friendly interface, are expected to fuel the adoption of the cloud-based mode of operation.
• North America capturedthe largest market share of around 36% in 2015. The dominance of the segment is expected to continue with a CAGR of 5.8% from 2016 to 2024.
• The factors contributing to the growth of the North America market include the increasing prevalence of heart diseases and the technological advancements in the region. Moreover, factors, such as the availability of highly advanced healthcare facilities and the higher adoption rate of the data management tools are augmenting the market growth in North America.
• Asia Pacific is anticipated to grow at the fastest rate during the forecast period. Countries, such as India and China are expected to be the fastest growing markets in the region owing to the large pool of cardiovascular patients and the rising healthcare expenditure.
• The booming medical tourism in Asia Pacific due to the availability of advanced healthcare facilities and services at a lower cost in comparison to the other developed countries serves as the pivotal factor in attracting cardiac patients worldwide to this region.
• Some major players in this market include Philips Healthcare, GE Healthcare, McKesson Corporation, Siemens Healthcare GmbH, Merge Healthcare, Inc., Agfa Healthcare N.V., Cerner Corporation, Fujifilm Medical Systems, Inc., Lumedx Corporation, and Digisonics, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Cardiovascular Information System (CVIS) Market on the basis of system type, mode of operation, and geography.

Cardiovascular information system (CVIS) market, by system, 2013 - 2024 (USD Million)

• CVIS
• CPACS 

Cardiovascular information system (CVIS) market, by mode of operation, 2013 - 2024 (USD Million)

• Web-based
• On-site
• Cloud-based 

Cardiovascular information system (CVIS) market, by region, 2013 - 2024 (USD Million)

• North America
• U.S. Cardiovascular Information System, by Systems
• Canada Cardiovascular Information System, by Systems
• U.S. Cardiovascular Information System, by Mode of Operation
• Canada Cardiovascular Information System, by Mode of Operation
• Europe
• U.K. Cardiovascular Information System, by Systems
• Germany Cardiovascular Information System, by Systems
• U.K. Cardiovascular Information System, by Mode of Operation
• Germany Cardiovascular Information System, by Mode of Operation
• Asia Pacific
• China Cardiovascular Information System, by Systems
• India Cardiovascular Information System, by Systems
• China Cardiovascular Information System, by Mode of Operation
• India Cardiovascular Information System, by Mode of Operation
• Latin America
• Brazil Cardiovascular Information System, by Systems
• Mexico Cardiovascular Information System, by Systems
• Brazil Cardiovascular Information System, by Mode of Operation
• Mexico Cardiovascular Information System, by Mode of Operation
• MEA
• South Africa Cardiovascular Information System, by Systems
• South Africa Cardiovascular Information System, by Mode of Operation

View Press Release On Global Cardiovascular Information System (CVIS) Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiovascular-information-system-cvis-market        

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiac Prosthetic Device Market Is Segmented On The Basis Of Product 2014-2025

Global Cardiac Prosthetic Device Market is expected to be over USD 8.7 billion by 2025, based on a new study by Grand View Research, Inc. Rising demand for minimally invasive devices has provided greater growth prospects for the market. New product development through technological advancements is anticipated to foster market growth. The major companies are focusing on expanding their product life and safety benefits of the cardiac prosthetic devices. Such initiatives undertaken by the key players have resulted in increasing survival rates and low stroke rates for transcatheter aortic valves.

Transcatheter Aortic Valve Replacement (TAVR) is covered by Evidence Development (CED) Coverage provided by the Centers for Medicare & Medicaid Services (CMS). Cardiac pacemakers are also covered under Medicare program. Initiatives for reimbursement from the government for such devices are anticipated to boost the demand for cardiac prosthetic devices.

Access Full Research Report on Global Cardiac Prosthetic Device Market:
http://www.grandviewresearch.com/industry-analysis/cardiac-prosthetic-devices-market

Further Key Findings From the Study Suggest:

• Heart valve segment was one of the largest segments in 2015 owing to rising prevalence of valvular disease and heart valve failure.
• Pacemakers segment is expected to grow significantly, owing to rising reimbursement policies for pacemaker-related surgeries.
• Mechanical heart valve segment contributed toward the one of the largest market share in 2015 owing to its increasing product longevity. Moreover, they provide better hemodynamic efficiency. Since mechanical valves are made up of strong durable materials, such as titanium and carbon, they are preferred over other cardiac prosthetic devices.
• Transcatheter valve is expected to exhibit lucrative CAGR over the forecast period. TAVR has shown improved patient survival rate as compared to medical therapy. In the past years, it has evolved as a minimally invasive alternative treatment for surgical valve replacement.
• Implantable pacemakers are one of the highest revenue generating segments owing to their greater applicability pertaining to heart failure (HF) and other cardiovascular diseases like stroke.
• North America contributed toward the largest market share of around 40.0% in 2015. This is primarily due to the fact that the number of pacemaker implantations has increased amongst the Americans over the past two decades. Moreover, companies are focusing on commercial availability of technologically advanced devices in the U.S.
• Asia Pacific is anticipated to witness highest CAGR over the forecast period owing to the growing geriatric population in Japan. In 2015, the geriatric population base accounted for around 27% in Japan.
• Some key companies in this market are Medtronic, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Abbott Vascular; Siemens Healthcare GmbH; and Sorin Group.
• New product development through introduction of advanced technology and mergers & acquisitions are some of the key strategies adopted by the companies to enhance the demand for cardiac prosthetic devices. For instance, in 2015, St. Jude Medical and Thoratec, a company that specializes in mechanical circulatory support technology for the treatment of advanced HF, entered into a definitive agreement aiming at acquisition of the outstanding shares of Thoratec.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Cardiac Prosthetic Device Market on the basis of product:

Cardiac prosthetic device market Product Outlook (Market Revenue in USD Million, 2014 - 2025)

• Heart valves

·         Mechanical valve

·         Tissue valve

§  Stented tissue valve

§  Stentless tissue valve

·         Transcatheter valve

·         Pacemakers

·         Implantable pacemakers

§  Single-Chamber Battery Pacemaker

§  Dual-Chamber Battery Pacemaker

§  Triple-Chamber Battery Pacemaker

·         External pacemakers

Cardiac prosthetic device market Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa
• South Africa

View Press Release On Global Agricultural Robots Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-prosthetic-devices-market       

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiac Biomarkers Market Is Segmented On The Basis Of Type, Application, End Use, And Region 2013-2024

Cardiac Biomarkers Market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease diagnosis. Furthermore, this growth is attributed to a majority of factors, such as the high prevalence of Acute Coronary Syndrome (ACS), continual technological advancements in the development of cardiovascular biomarkers, increasing number of new product launches by the key market players, rising demand for point of care cardiac testing kits, along with the high specificity and sensitivity of these biomarkers in the detection of cardiovascular diseases, especially acute myocardial infarction.

The cardiac biomarkers market has been classified by type into troponin, Creatine kinase-MB(CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), myoglobin, and others. Troponin is a heteromeric protein and comprises cardiac troponin T & I, which are abbreviated as cTnT & cTnI, respectively. The troponin biomarkers segment is expected to grow lucratively in the forecast period at a significant CAGR. The diagnostic efficiency and specificity related to cardiac biomarker testing renders it a universally gold standard test to diagnose cardiovascular disorders worldwide. The market by application is segmented into acute coronary syndrome, myocardial infarction, congestive heart failure, and others. ACS is expected to be the highest grossing segment according to the study. ACS is responsible for huge medical costs globally and is responsible for most hospital readmission cases. The increasing efforts to cut down worldwide ACS prevalence rates are expected to drive the growth of the biomarkers market.

The key countries included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and the Middle East. North America accounted for the largest market in 2015, whereas the Asia Pacific region is anticipated to be the fastest growing region during the forecast period.

Full Research Report on Global Cardiac Bio-makers Market:
http://www.grandviewresearch.com/industry-analysis/cardiac-biomarker-market

Further key findings from the study suggest:

• North America is estimated to dominate the global cardiac biomarkers market. The high prevalence of coronary heart disease in western countries is one of the major factors contributing to the high demand for cardiac biomarker diagnostics.
• The Asia Pacific region is anticipated to be the fastest growing region in the study period owing to the large population, especially in China and India. Apart from that, there exists a high prevalence rate of myocardial infarction in the region. This prevalence rate is expected to fuel the demand for cardiac biomarker diagnostics.
• The troponin biomarker segment is expected to grow at a significant rate, and is expected to grow at the highest CAGR compared to others and accounts for the largest market share in 2015.
• The sector comprises of several local as well as global players. Some of the major players of this vertical include Alere, Inc., Siemens Healthcare GmbH, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and bioMerieux SA.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Cardiac Biomarkers Market on the basis of type, application, end use, and region:

Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 - 2024)

• Troponin
• CK-MB
• Natriuretic peptides - BNP and NT-proBNP
• Myoglobin
• Others

Cardiac Biomarkers Market Application Outlook (Revenue, USD Million, 2013 - 2024)

• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure
• Others

Cardiac Biomarkers Market End-use Outlook (Revenue, USD Million, 2013 - 2024)

• Laboratory Testing
• Point of Care Testing

Cardiac Biomarkers Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Middle East

View Press Release On Global Agricultural Robots Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-biomarker-market      

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com